Decreased Vessel Density in Retinal Capillary Plexus and Thinner Ganglion Cell Complex Associated With Cognitive Impairment

Background To determine the association of the retinal capillary plexus (RCP) and ganglion cell complex (GCC) with cognitive impairment using optical coherence tomography angiography (OCTA). Methods A cross-sectional, community-based study utilizing data from the participants enrolled between August 2019 and January 2020 in the Jidong Eye Cohort Study. We assessed the vessel density in RCP and GCC thickness using OCTA, and cognitive testing using the Montreal Cognitive Assessment (MoCA). Cognitive impairment in this study was defined as MoCA score < 24. We used multivariable analysis to evaluate the association of RCP and GCC with cognitive impairment after adjusting for confounders. Results This study analyzed 1555 participants. The mean age of participants was 52.3 (8.4) years, and 861 (55.4%) were women. Cognitive impairment was observed in 268 (17.2%) participants. The adjusted odds ratio (OR) with 95% confidence interval (95% CI) for parafovea vessel density in the deep RCP with cognitive impairment was 1.20 (1.03–1.39). For vessel area and length density surrounding foveal avascular zone with cognitive impairment, the ORs with 95% CIs were 1.23 (1.07–1.41) and 1.30 (1.13–1.49), respectively. For thickness in the superior GCC with cognitive impairment, the OR with 95% CI was 1.16 (1.01–1.32). Conclusion Lower vessel density in the RCP and thinner GCC were associated with cognitive impairment. Our results suggest that alterations in the RCP and GCC could provide further evidence when assessing the cognitive function and may even be potentially useful biomarkers in the detection of cognitive impairment.

[1]  L. Yeung,et al.  Investigation of Possible Correlation Between Retinal Neurovascular Biomarkers and Early Cognitive Impairment in Patients With Chronic Kidney Disease , 2021, Translational vision science & technology.

[2]  T. Wong,et al.  Retinal imaging in Alzheimer’s disease , 2021, Journal of Neurology, Neurosurgery, and Psychiatry.

[3]  D. Ding,et al.  Decreased Retinal Vascular Density in Alzheimer’s Disease (AD) and Mild Cognitive Impairment (MCI): An Optical Coherence Tomography Angiography (OCTA) Study , 2021, Frontiers in Aging Neuroscience.

[4]  Cason B. Robbins,et al.  The application of optical coherence tomography angiography in Alzheimer's disease: A systematic review , 2021, Alzheimer's & dementia.

[5]  T. Wong,et al.  Retinal microvasculature dysfunction is associated with Alzheimer’s disease and mild cognitive impairment , 2020, Alzheimer's research & therapy.

[6]  F. Lu,et al.  The Jidong Eye Cohort Study: objectives, design, and baseline characteristics , 2020, Eye and Vision.

[7]  P. Snyder,et al.  Retinal imaging in Alzheimer's and neurodegenerative diseases , 2020, Alzheimer's & dementia : the journal of the Alzheimer's Association.

[8]  J. Wardlaw,et al.  The Application of Optical Coherence Tomography Angiography in Cerebral Small Vessel Disease, Ischemic Stroke, and Dementia: A Systematic Review , 2020, Frontiers in Neurology.

[9]  Jeremiah K. H. Lim,et al.  Retinal changes in Alzheimer's disease— integrated prospects of imaging, functional and molecular advances , 2020, Progress in Retinal and Eye Research.

[10]  B. Kennedy,et al.  Three-dimensional facial-image analysis to predict heterogeneity of the human ageing rate and the impact of lifestyle , 2020, Nature Metabolism.

[11]  Naaheed Mukadam,et al.  Dementia prevention, intervention, and care: 2020 report of the Lancet Commission , 2020, The Lancet.

[12]  M. Breteler,et al.  Association of retinal layer measurements and adult cognitive function , 2020, Neurology.

[13]  M. Rakuša,et al.  The validity of the Montreal cognitive assessment (MoCA) for the screening of vascular cognitive impairment after ischemic stroke , 2020, Acta Neurologica Belgica.

[14]  A. Ljubimov,et al.  Identification of early pericyte loss and vascular amyloidosis in Alzheimer’s disease retina , 2020, Acta Neuropathologica.

[15]  Huamin Liu,et al.  Jidong cognitive impairment cohort study: objectives, design, and baseline screening , 2019, Neural regeneration research.

[16]  Xia Feng,et al.  Association between Serum Uric Acid and Non-Alcoholic Fatty Liver Disease according to Different Menstrual Status Groups , 2019, Canadian journal of gastroenterology & hepatology.

[17]  Tien Yin Wong,et al.  Macular Vessel Density Measured With Optical Coherence Tomography Angiography and Its Associations in a Large Population-Based Study. , 2019, Investigative ophthalmology & visual science.

[18]  James R. Burke,et al.  Retinal Microvascular and Neurodegenerative Changes in Alzheimer's Disease and Mild Cognitive Impairment Compared with Control Participants. , 2019, Ophthalmology. Retina.

[19]  P. Scheltens,et al.  Is retinal vasculature a biomarker in amyloid proven Alzheimer's disease? , 2019, Alzheimer's & dementia.

[20]  Maqsood Yaqub,et al.  Optical coherence tomography angiography in preclinical Alzheimer’s disease , 2019, British Journal of Ophthalmology.

[21]  L. Leocani,et al.  Functional and morphological changes of the retinal vessels in Alzheimer’s disease and mild cognitive impairment , 2019, Scientific Reports.

[22]  N. Kung,et al.  Association of Preclinical Alzheimer Disease With Optical Coherence Tomographic Angiography Findings , 2018, JAMA ophthalmology.

[23]  Geraint Rees,et al.  Association of Retinal Nerve Fiber Layer Thinning With Current and Future Cognitive Decline: A Study Using Optical Coherence Tomography , 2018, JAMA neurology.

[24]  Jianhua Wang,et al.  Altered birefringence of peripapillary retinal nerve fiber layer in multiple sclerosis measured by polarization sensitive optical coherence tomography , 2018, Eye and Vision.

[25]  Shiv Saidha,et al.  Emerging Applications of Optical Coherence Tomography Angiography (OCTA) in neurological research , 2018, Eye and Vision.

[26]  R. Dobson,et al.  A Decade of Blood Biomarkers for Alzheimer’s Disease Research: An Evolving Field, Improving Study Designs, and the Challenge of Replication , 2017, Journal of Alzheimer's disease : JAD.

[27]  James G. Fujimoto,et al.  Optical coherence tomography angiography , 2017, Progress in Retinal and Eye Research.

[28]  Giovanni Gregori,et al.  Altered Macular Microvasculature in Mild Cognitive Impairment and Alzheimer Disease , 2017, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.

[29]  Mehmet Bulut,et al.  Evaluation of optical coherence tomography angiographic findings in Alzheimer’s type dementia , 2017, British Journal of Ophthalmology.

[30]  P. Snyder,et al.  Blood-based biomarkers in Alzheimer disease: Current state of the science and a novel collaborative paradigm for advancing from discovery to clinic , 2017, Alzheimer's & Dementia.

[31]  Gangjun Liu,et al.  Optical Coherence Tomography Angiography , 2016, Investigative ophthalmology & visual science.

[32]  Jaewan Choi,et al.  Systemic and Ocular Hemodynamic Risk Factors in Glaucoma , 2015, BioMed research international.

[33]  C. Hammond,et al.  How strong is the relationship between glaucoma, the retinal nerve fibre layer, and neurodegenerative diseases such as Alzheimer’s disease and multiple sclerosis? , 2015, Eye.

[34]  M. Carrillo,et al.  Summary of the evidence on modifiable risk factors for cognitive decline and dementia: A population-based perspective , 2015, Alzheimer's & Dementia.

[35]  J. McQuaid,et al.  The Montreal Cognitive Assessment , 2015, Journal of the International Association of Providers of AIDS Care.

[36]  J. Mortimer,et al.  Prevalence of mild cognitive impairment in an urban community in China: A cross-sectional analysis of the Shanghai Aging Study , 2015, Alzheimer's & Dementia.

[37]  Xiang Gao,et al.  Ideal Cardiovascular Health Metrics and the Risks of Ischemic and Intracerebral Hemorrhagic Stroke , 2013, Stroke.

[38]  Thomas D Koepsell,et al.  Reversion from mild cognitive impairment to normal or near-normal cognition , 2012, Neurology.

[39]  N. Venketasubramanian,et al.  The Montreal Cognitive Assessment is superior to the Mini-Mental State Examination in detecting patients at higher risk of dementia , 2012, Alzheimer's & Dementia.

[40]  James G. Fujimoto,et al.  Motion correction in optical coherence tomography volumes on a per A-scan basis using orthogonal scan patterns , 2012, Biomedical optics express.

[41]  C. Laske Blood-based biomarkers in Alzheimer disease. , 2011, Archives of neurology.

[42]  R. Mayeux,et al.  Epidemiology of Alzheimer disease , 2011, Nature Reviews Neurology.

[43]  C. Klein,et al.  VALIDITY OF THE MoCA AND MMSE IN THE DETECTION OF MCI AND DEMENTIA IN PARKINSON DISEASE , 2010, Neurology.

[44]  J. Cummings,et al.  The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment , 2005, Journal of the American Geriatrics Society.

[45]  C. Miller,et al.  Optic-nerve degeneration in Alzheimer's disease. , 1986, The New England journal of medicine.

[46]  M. Mimura,et al.  Quantitative Assessment of the Retina Using OCT and Associations with Cognitive Function. , 2019, Ophthalmology.

[47]  K. Blennow,et al.  Blood-based biomarkers for Alzheimer’s disease: mapping the road to the clinic , 2018 .

[48]  C. Jack,et al.  Framework : Towards a Biological Definition of Alzheimer ’ s Disease 1 2 draft 9-19-17 3 4 5 , 2017 .

[49]  Tien Yin Wong,et al.  Retinal ganglion cell analysis using high-definition optical coherence tomography in patients with mild cognitive impairment and Alzheimer's disease. , 2015, Journal of Alzheimer's disease : JAD.

[50]  M. Schwartz,et al.  The retina as a window to the brain—from eye research to CNS disorders , 2013, Nature Reviews Neurology.

[51]  斎藤尚宏,et al.  The Montreal Cognitive Assessment (MoCA)によるパーキンソン病の認知機能の検討 , 2010 .

[52]  G. Ripandelli,et al.  Optical coherence tomography. , 1998, Seminars in ophthalmology.